Skip to main content

Table 1 Observational Studies in Children with Nephrotic Syndrome

From: The rationale and design of Insight into Nephrotic Syndrome: Investigating Genes, Health and Therapeutics (INSIGHT): a prospective cohort study of childhood nephrotic syndrome

Author

Year

N

Ethnicity

Mean Age at Onset?±?SD, yrs (Range)

Male (%)

Mean Follow-Up Time?±?SD, yrs (Range)

Steroid Resistant (%)

Retrospective Studies

       

Ingulli [5]

1991

177

Black & Hispanic

7.3?±?4.6

No data

8.25?±?4.3

15.3%

    

(1.0-16.75)

 

(1-15)

 
  

65

Caucasian

7.8?±?4.8

 

8.8?±?4.1

6.2%

    

(2-14.8)

 

(2-14.8)

 

Bircan [8]

2002

138

Turkish

4.9?±?3.56

61.2%

3.4?±?2.31

13.2%

    

(1-15)

 

(1-6)

 

Ozkaya [9]

2004

392

Turkish

4.6?±?3.4

59.2%

2

23%b

    

(0.9-16)a

   

Kim [10]

2005

103

Caucasian

4.3?±?3.5

51%

No data

3.6%

  

96

African-American

8.2?±?5.2

 

No data

11%

Bhimma [3]

2006

816

Black & Indian

4.8

60.4%

2.5

27.3%

    

(1.2-16)

 

(0.1-16.5)

 

Chang [11]

2009

99

Chinese

8.35?±?4.61

73.7%

5.06?±?4.35

N/Ae

    

(2-18)

   

Mubarak [6]

2009

538

Pakistani

9.79?±?4.59

64.4%

No data

31.1%

    

(0.8-18)a

   

Otukesh [12]

2009

73

Iranian

5.9

52.0%

6.0?±?4.2

100%

      

(0.5-16)

 

Copelovitch [4]

2010

112

Cambodian

8.95

63.4%

15.1

6.25%

    

(0.6-15.75)

 

(3.7-2.73)

 

Banaszak [13]

2012

76

Caucasian (Poland)c

2.7 (median)

54.5%

No data

15.8%

  

102

Caucasian (Poland)d

3.3 (median)

68%

No data

31.3%

Prospective Studies

       

Kumar [14]

2003

290

Northern and Eastern Indian

7.9?±?5.1

73.4%

No data

38%b

Wong [15](Registry)

2007

49

New Zealand European, Maori, Pacific Islander, Asian, Other

6.1?±?3.8

71.4%

1

19.6%

Bakkali [16](Registry)

2011

231

No data (Netherlands)

5.08

67.1%

4

N/Ae

  1. a indicates age of study group, where age at onset not specified.
  2. b estimated based on participants diagnosed with FSGS.
  3. c indicates patients treated with NS between 1986-1995.
  4. d indicates patients treated with NS between 1996-2005.
  5. e no steroid resistance reported.